MAPT and Alzheimer disease: The H2‐haplotype in MAPT has also been reported to reduce the risk of late‐onset AD,8 and rs393152, a single‐nucleotide polymorphism (SNP) at the MAPT locus, was reported to significantly increase the risk of AD.9